investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Joseph H Antin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Hamid Band

Tyrosine Kinase Regulation Via Protein Degradation

Leukaemia

Hematology and hematologic malignancies Pathology

M. James You

CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF

Leukaemia

Eduardo Sotomayor

Studies on the Etiopathogenesis of T-Cell Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Effie W Petersdorf

Clinical Significance of MHC Haplotypes in HCT

Leukaemia

Daniel G Tenen

Mechanisms of regulation by RNA in acute myeloid leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Alan Rein

Retrovirus Assembly and Maturation - Rockville

Leukaemia

Pathology Hematology and hematologic malignancies

David Marc Weinstock

Polysomy 21 in Acute Lymphoblastic Leukemia

Leukaemia

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Leukaemia

Hematology and hematologic malignancies Pathology

Vinay Pathak

Retroviral Replication and Interactions with Host Factors

Leukaemia

Hematology and hematologic malignancies Pathology